USPTO serial 79394242
Reviewed by CopyMark Law Group
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Robyn Lederman
Robyn Lederman Brooks Kushman P.C.150 W. Second Street, Suite 400NRoyal Oak, MI 48067United States| Class | Description | Status | First use |
|---|---|---|---|
| 042 | Development and testing of software, namely, of methods and algorithms for use in software; software as a service featuring artificial intelligence software for use in drug research and development, clinical trials, biomarker research and development, translational research and development, diagnostic testing, clinical testing, and clinical diagnostics; biological research; clinical research in the field of digital pathology; medical research; scientific research in the nature of conducting clinical trials for others; providing medical and scientific research information about the results of clinical trials for pharmaceuticals; providing medical and scientific research information about the results of clinical trials for pharmaceuticals; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; providing online non-downloadable computer software platforms for scientific research and clinical diagnostics | ACTIVE | — |
| 044 | Medical pathology services; pathological testing for diagnostic or research or treatment purposes; medical analysis for diagnostic or treatment purposes provided by medical laboratories; remote monitoring of medical data for medical treatment; medical laboratory analysis services relating to the treatment of persons; medical analysis services relating to the treatment of patients; medical analysis services relating to the treatment of persons provided by medical laboratories; providing information in the field of cancer prevention, screening, diagnosis and treatment | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 14, 2026 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Apr 16, 2026 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Oct 10, 2025 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Sep 24, 2025 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Sep 24, 2025 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Aug 18, 2025 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Aug 8, 2025 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Feb 6, 2025 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Feb 6, 2025 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Feb 6, 2025 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Jan 16, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 16, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 16, 2025 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 26, 2024 | RFNT | REFUSAL PROCESSED BY IB | — |
| Oct 7, 2024 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Oct 7, 2024 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Oct 3, 2024 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Oct 2, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 22, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| May 7, 2024 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| May 7, 2024 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 25, 2024 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |